The goal is not to import “fail fast” wholesale into medicine. Nor is it to preserve a system so risk-averse that it limits ...

It’s crucial to have invested in this foundational infrastructure to be able to move quickly and keep up with the speed of change. The Fast Company Executive Board is a private, fee-based network of ...

Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now As entrepreneurs, we’re all familiar with ...

When launching a new concept, an unproven idea, it is often more important to get something to market quickly than it is to continue to refine the concept privately. For years, we have advised ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. "Ever tried. Ever failed. No matter. Try again. Fail again. Fail better." Irish playwright Samuel ...

If you’ve talked to an engineering nerd or a tech bro recently, you’ve probably heard the phrase “fail fast, fail often” a lot. The idea is simple: Value trying and learning from failure rather than ...

Opinions expressed by Entrepreneur contributors are their own. “You dare to fail fast,” read the job description for a leadership role at a burgeoning startup. Pretty stark, and with a meaning that ...

A strong spirit of innovation and action is contagious among employees at BJC Healthcare. In December, leaders planted the seeds for a virtual nursing program and, just five weeks later, the pilot was ...

From decreasing dependence on petroleum to decarbonizing the ocean, innovations at the intersection of deep tech and sustainability may be the future of entrepreneurship. Undergraduates and graduate ...

This is the second article in a two-part series. In the first article, AlixPartners shared a framework and approach to get on track with Generative AI and drive value for retailers and brands. This ...

The pharmaceutical industry does not lack ambition. It lacks early signal clarity. More than 90% of drugs entering clinical trials fail. Behind that statistic sits a stark economic reality: billions ...